Intranasal Drug and Vaccine Delivery Market, By Product Type (Nasal Drops and Nasal Sprays), By Application (Vaccination, Pain Management, Respiratory Disorders, and Others), By End-user (Hospitals, ...

DUBLIN--(BUSINESS WIRE)--ResearchAndMarkets.com, a leading provider of market research products, is pleased to announce the addition of the Nasal Drug Delivery Technology Market Report 2023-2033 ...

Nasal drug delivery is now emerging as a promising route for the rapid delivery of certain classes of molecules.

SciSparc has identified a new way to get its cannabinoid receptor type 2 (CB2R) agonist to targets in the brain. Having run initial studies on an intravenous formulation, the Israeli biotech is now ...

SARASOTA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related disorders, today announced that ...

Polyrizon Ltd., a biotechnology company focused on intranasal drug delivery systems, has reported promising preclinical results for its hydrogel-based Trap & Target (T&T) platform, developed in ...

A company that’s poised to disrupt the nasal drug delivery market has signed a licensing deal with Avanir Pharmaceuticals (Nasdaq: AVNR) valued at $110 million. OptiNose’s drug delivery system in ...

Strategic collaboration with leading global manufacturer of drug delivery systems strengthens NS002's clinical and commercial ...

Polyrizon Ltd., a biotech company based in Raanana, Israel, announced the publication of a national phase patent application by the USPTO for its innovative intranasal hydrogel technologies. These ...

Polyrizon plans to continue preclinical validation and advance toward clinical trials as part of the development path for the C&C platform.

Raanana, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal ...

The evaluation was led by Professor Fabio Sonvico from the Department of Food and Drug at the University of Parma, a leading authority in intranasal and pulmonary drug delivery and a member of ...